XML 48 R38.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock Option Plans (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Stock Option Activity

A summary of changes in options issued under the Company’s stock option plans follows:

 

 

 

2024

 

 

2023

 

Options outstanding at the beginning of the year

 

 

1,598,761

 

 

 

1,617,672

 

Options granted

 

 

37,500

 

 

 

163,500

 

Options forfeited

 

 

(10,500

)

 

 

(6,938

)

Options exercised

 

 

(222,671

)

 

 

(175,473

)

Options outstanding at the end of the year

 

 

1,403,090

 

 

 

1,598,761

 

Options exercisable at the end of the year

 

 

1,126,972

 

 

 

1,138,706

 

Common stock available for future grants at the end of the year

 

 

223,875

 

 

 

3,250

 

Weighted average exercise price per share:

 

 

 

 

 

 

Granted

 

$

38.26

 

 

$

30.47

 

Forfeited

 

 

31.63

 

 

 

20.68

 

Exercised

 

 

21.87

 

 

 

16.95

 

Outstanding

 

 

27.82

 

 

 

26.77

 

Exercisable

 

 

26.61

 

 

 

24.82

 

Summary of Options Outstanding

A summary of options outstanding as December 31, 2024 is as follows:

 

Options Outstanding

 

 

Options Exercisable

 

Range of Exercise Prices

 

Number
Outstanding

 

 

Weighted-
Average
Remaining
Contractual
Life (Years)

 

Weighted-
Average
Exercise
Price

 

 

Number
Exercisable

 

 

Weighted-
Average
Exercise
Price

 

$19.23 to $22.86

 

 

338,454

 

 

3

 

$

21.48

 

 

 

338,454

 

 

$

21.48

 

$22.87 to $24.03

 

 

304,637

 

 

4

 

 

23.46

 

 

 

304,637

 

 

 

23.46

 

$24.04 to $29.91

 

 

286,374

 

 

5

 

 

27.00

 

 

 

220,499

 

 

 

26.30

 

$29.92 to $38.09

 

 

225,875

 

 

8

 

 

31.56

 

 

 

93,505

 

 

 

32.85

 

$38.10 to $39.56

 

 

247,750

 

 

7

 

 

39.38

 

 

 

169,877

 

 

 

39.47

 

 

 

 

1,403,090

 

 

 

 

 

 

 

 

1,126,972

 

 

 

 

Assumptions Used to Value Option Grants

The assumptions used to value option grants for the years ended December 31, 2024 and 2023 were as follows:

 

 

 

2024

 

 

2023

 

Expected life in years

 

7

 

 

7

 

Interest rate

 

 

3.85

%

 

 

4.17

%

Volatility

 

0.455

 

 

0.422

 

Dividend yield

 

 

1.5

%

 

 

1.8

%

 

Summary of the Status of the Company's Non-Vested Options

A summary of the status of the Company’s non-vested options as of December 31, 2024 and 2023 follows:

 

For the twelve months ended December 31, 2024

 

 

 

 

 

 

 

 

Number of Awards

 

 

Weighted Average Grant Date Fair Value

 

Unvested Outstanding, beginning of year

 

 

460,055

 

 

$

11.81

 

Granted

 

 

37,500

 

 

 

17.16

 

Cancelled/Forfeited

 

 

(8,875

)

 

 

12.00

 

Expired

 

 

 

 

 

 

Vested, outstanding shares

 

 

(212,562

)

 

 

11.31

 

Unvested Outstanding, end of year

 

 

276,118

 

 

$

12.91

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the twelve months ended December 31, 2023

 

 

 

 

 

 

 

 

Number of Awards

 

 

Weighted Average Grant Date Fair Value

 

Unvested Outstanding, beginning of year

 

 

485,498

 

 

$

10.77

 

Granted

 

 

163,500

 

 

 

12.65

 

Cancelled/Forfeited

 

 

(875

)

 

 

11.10

 

Expired

 

 

 

 

 

 

Vested, outstanding shares

 

 

(188,068

)

 

 

9.86

 

Unvested Outstanding, end of year

 

 

460,055

 

 

$

11.81